Painkillers Lower Levels of Prostate Cancer Biomarker
Common painkillers like aspirin and ibuprofen appear to lower a mans PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer.
Read MorePosted by Clinical Lab Products | Sep 9, 2008 | Cancer, Miscellaneous |
Common painkillers like aspirin and ibuprofen appear to lower a mans PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer.
Read MorePosted by Clinical Lab Products | Sep 1, 2008 | Cancer, Miscellaneous |
Start-ups and the NCI pioneer novel technologies for disease detection
Read MorePosted by Clinical Lab Products | Aug 19, 2008 | Cancer, Miscellaneous |
Blood tests to check levels of the so-called sunshine vitamin are on the rise as doctors and patients react to headline-grabbing research that suggests having too little may not only hurt your bonesit might increase your risk of certain cancers or heart disease.
Read MorePosted by Clinical Lab Products | Aug 12, 2008 | Cancer, Miscellaneous |
Health Discovery Corporation has announced that their new gene-based molecular diagnostic test for prostate cancer has now successfully completed its Phase III double-blind clinical trial and is now ready for commercialization. It will be presented at the upcoming Biomarker Discovery Europe 2008 conference in Dublin, Ireland on October 2-3.
Read MorePosted by Clinical Lab Products | Aug 11, 2008 | Cancer, Miscellaneous |
Prostate cancer diagnosis tends to be delayed and surgical treatment more difficult in obese men than in lean men, according to two recently published studies.
Read More